|
Govt in the process of evaluating proposals for bulk drug parks: Minister
|
|
Our Bureau, New Delhi
July 28 , 2022
|
|
|
The ministry of chemicals and fertizers has said that the proposals it has received from the States under the Scheme for Promotion of Bulk Drug Parks are currently under evaluation.
India exported about Rs. 33,321 crore worth of active pharmaceutical ingredients (APIs) and bulk drugs in the year 2021-22, while imported Rs. 35,249 crore worth of bulk drugs.
The Scheme for Promotion of Bulk Drug Parks, with a financial outlay of Rs. 3,000 crore and the tenure from FY 2020-2021 to FY 2024-25, provides for financial assistance to three states for establishing Bulk Drug Parks. For the fiscal year 2022-23, the Union Budget has allocated around Rs. 900 crore for promotion of bulk drug parks, as compared to the Rs. 36.24 crore spent in the previous year. The government has earlier said that it has received applications from around 13 states to set up bulk drug parks in their region.
The financial assistance by the Centre is subject to a maximum limit of Rs.1,000 crore per park or 70% of the project cost of CIF ( 90% in case of North Eastern States and Hilly States i.e. Himachal Pradesh, Uttarakhand, UT of Jammu & Kashmir and UT of Ladakh), whichever is less.
“The proposals received from the states under the scheme are under evaluation,” said minister of state for chemicals and fertilisers, Bhagwanth Khuba, in a written reply in Rajya Sabha this week.
Under the scheme, financial assistance would be provided for creation of Common Infrastructure Facilities (CIF) like (i) Central Effluent Treatment Plant(s) (CETP) (ii) Solid waste management (iii) Storm water drains network (iv) Common Solvent Storage System, Solvent recovery and distillation plant (v) Common Warehouse (vi) Dedicated power sub-station and distribution system with the necessary transformers at factory gate (vii) Raw, Potable and Demineralized Water (viii) Steam generation and distribution system (ix) Common cooling system and distribution network (x) Common logistics (xi) Advanced laboratory testing Centre, suitable for even complex testing/research needs of APIs, including microbiology laboratory and stability chambers (xii) Emergency Response Centre (xiii) Safety/Hazardous operations audits centre and (xiv) Centre of Excellence etc. in any upcoming Bulk Drug Park promoted by State Government/State Corporation.
The common infrastructure facilities created under the scheme will help reduce the manufacturing cost of bulk drugs and also enhance the competitiveness of the domestic industry.
Khuba said that in order to make the country Atmanirbhar in APIs and drug intermediates, the Department of Pharmaceuticals is implementing the production linked incentive (PLI) scheme for promotion of domestic manufacturing critical key starting materials (KSMs)/drug intermediates (DIs) and APIs in the country with a financial outlay of Rs. 6,940 crore in a tenure from FY 2020-21 to FY 2029-30, and a total of 51 applicants have been selected for the scheme. Besides, the PLI scheme for pharmaceuticals with a financial outlay of Rs. 15,000 crore is also implemented from FY 2020-21 to FY 2028-29 providing financial incentive to 55 selected applicants for manufacturing of identified products under three categories for a period of six years.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|